Gemtuzumab Chemotherapy MRD Levels; Glasdegib Post-transplant, Adult Untreated, de Novo, Fav Interm Risk AML

Condition:   Acute Myeloid Leukemia Interventions:   Drug: Glasdegib;   Drug: Gemtuzumab Ozogamicin Sponsor:   Gruppo Italiano Malattie EMatologiche dell'Adulto Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials